Costall B, Gunning S J, Naylor R J, Tyers M B
Br J Pharmacol. 1987 Jun;91(2):263-4. doi: 10.1111/j.1476-5381.1987.tb10280.x.
The effects of GR38032F a novel, selective and potent 5-hydroxytryptamine (5-HT3)-receptor antagonist on gastric emptying in the guinea-pig were investigated and compared to those of metoclopramide and haloperidol. Both GR38032F and metoclopramide increased gastric emptying in a dose-dependent manner. In contrast, haloperidol was ineffective. GR38032F was about 200 times more potent than metoclopramide in enhancing gastric emptying over the 2 h period studied.
研究了新型、选择性且强效的5-羟色胺(5-HT3)受体拮抗剂GR38032F对豚鼠胃排空的影响,并与胃复安和氟哌啶醇进行了比较。GR38032F和胃复安均以剂量依赖方式增加胃排空。相比之下,氟哌啶醇无效。在研究的2小时期间,GR38032F增强胃排空的效力比胃复安高约200倍。